The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'July 2020'. If you still can't find what you are looking for, try using the search box.
San Diego, California and Saffron Walden, UK: Invivoscribe, Inc., an industry pioneer and global leader in the field of precision diagnostics announces the launch of a fully integrated drug development engine. This new engine will combine with its in-house expertise in diagnostics development and worldwide access to patients and clinical testing capabilities to accelerate drug development.
Invivoscribe’s therapeutics division also announced today that the company has in-licensed technology involving a preclinical molecule and associated small molecules from Domainex Ltd. Domainex is a rapidly growing, well established integrated drug discovery service company in the UK that has utilized its novel, proprietary technologies to develop a first-in-class small molecule program against a difficult to target enzyme. Under the license agreement, Invivoscribe will develop and commercialize certain molecules generated by Domainex as oral immunotherapy agents to treat hem ...
Read the rest of entry »
£30 Million is available to support industry-led research and development projects that seek to provide solutions to Health and Care challenges.
Recombinant engineered antibodies for COVID-19 diagnostics and therapeutic development
Reading Scientific Services Ltd (RSSL) has received the MHRA-recognised Cogent Gold Standard approval for its Responsible Person (RP) training course. The announcement follows a rigorous 18-month process, during which RSSL successfully developed and mapped all of its course material against the Gold Standard requirements.
Take advantage of this discount to attend the premier Middle East Conference of the year
This event will kick off with an introduction from Danielle Folkard, Oxford Nanopore Technologies Ltd. and a Q&A session. Attendees will then hear from local users about their research using nanopore sequencing
Registration is now open for our first Life Sciences Live webinar on Thursday 16 July at 10.30am
TOSP is pleased to announce that its newest facility, the 30,000 sq ft Bellhouse Building, has reached practical completion. The first occupiers are expected to move in by the end of the summer, and there is high demand for the rest of the space.
A guide through these unfamiliar waters and for preparing your business for getting back to normal working arrangements.
Watch Evotec's EVP of Anti-infectives Lloyd Payne speak with Forge Therapeutics CEO Zak Zimmerman about recent developments & partnerships in anti-infective drug discovery and development
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.